| scholarly article | Q13442814 |
| P2093 | author name string | Hallie S Rane | |
| Karlett J Parra | |||
| Samuel A Lee | |||
| Stella M Bernardo | |||
| Alba Chavez-Dozal | |||
| Maximillian Jahng | |||
| Vibhati V Kulkarny | |||
| P2860 | cites work | Candida albicans VPS1 contributes to protease secretion, filamentation, and biofilm formation | Q42278085 |
| Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals | Q42946675 | ||
| The relation of the plasma concentration of quinacrine to its antimalarial activity. | Q47932816 | ||
| Vacuolar dynamics during the morphogenetic transition in Candida albicans. | Q53433969 | ||
| Techniques for antifungal susceptibility testing of Candida albicans biofilms. | Q53857154 | ||
| Antimalarials | Q72636802 | ||
| Synergy, antagonism, and what the chequerboard puts between them | Q73521098 | ||
| Role of pH response in Candida albicans virulence | Q74322287 | ||
| In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms | Q84434680 | ||
| Antifungal lock therapy | Q27025682 | ||
| Identification of Saccharomyces cerevisiae genes conferring resistance to quinoline ring-containing antimalarial drugs | Q27937633 | ||
| A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast | Q28131611 | ||
| Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation | Q28379104 | ||
| Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers | Q28743513 | ||
| Candida biofilms: an update | Q30475833 | ||
| Candida albicans VMA3 is necessary for V-ATPase assembly and function and contributes to secretion and filamentation | Q30555316 | ||
| The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates | Q34112865 | ||
| Factors affecting filamentation in Candida albicans: changes in respiratory activity of Candida albicans during filamentation | Q34123462 | ||
| Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection | Q34142971 | ||
| The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. | Q35006284 | ||
| Candida biofilms and their role in infection | Q35044563 | ||
| Amphotericin B: current understanding of mechanisms of action | Q35247730 | ||
| Role of the V-ATPase in regulation of the vacuolar fission-fusion equilibrium | Q36016989 | ||
| Multiple methods of visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycle | Q36216944 | ||
| The where, when, and how of organelle acidification by the yeast vacuolar H+-ATPase | Q36416690 | ||
| Deletion of vacuolar proton-translocating ATPase V(o)a isoforms clarifies the role of vacuolar pH as a determinant of virulence-associated traits in Candida albicans | Q36647246 | ||
| Antifungal combinations against Candida albicans biofilms in vitro | Q36879905 | ||
| Essential role for vacuolar acidification in Candida albicans virulence | Q37151114 | ||
| The yeast lysosome-like vacuole: endpoint and crossroads | Q37266848 | ||
| Our current understanding of fungal biofilms | Q37622959 | ||
| New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. | Q38026787 | ||
| The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination | Q38637388 | ||
| Candida albicans biofilms produce antifungal-tolerant persister cells | Q39077924 | ||
| In vitro activity of antifungal combinations against Candida albicans biofilms | Q39526786 | ||
| 4-Aminoquinolines--past, present, and future: a chemical perspective | Q40866974 | ||
| Metabolism of alpha-factor by a mating type cells of Saccharomyces cerevisiae | Q40993410 | ||
| Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms | Q41912237 | ||
| Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans | Q41921505 | ||
| High affinity capture and concentration of quinacrine in polymorphonuclear neutrophils via vacuolar ATPase-mediated ion trapping: comparison with other peripheral blood leukocytes and implications for the distribution of cationic drugs | Q42265851 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida albicans | Q310443 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 7501-7509 | |
| P577 | publication date | 2014-10-06 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Quinacrine inhibits Candida albicans growth and filamentation at neutral pH. | |
| P478 | volume | 58 |
| Q90693077 | 'Acridines' as New Horizons in Antifungal Treatment |
| Q38526460 | Combinatorial drug approaches to tackle Candida albicans biofilms |
| Q61808000 | Drug Repurposing for the Treatment of Bacterial and Fungal Infections |
| Q41037695 | Effect of 2, 4-di-tert-butylphenol on growth and biofilm formation by an opportunistic fungus Candida albicans |
| Q92525201 | High Efficiency Drug Repurposing Design for New Antifungal Agents |
| Q38684254 | Proton Transport and pH Control in Fungi |
Search more.